Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Free Cash Flow (2018 - 2025)

AdaptHealth has reported Free Cash Flow over the past 8 years, most recently at $395.8 million for Q4 2025.

  • Quarterly results put Free Cash Flow at $395.8 million for Q4 2025, up 441.58% from a year ago — trailing twelve months through Dec 2025 was $535.9 million (up 127.28% YoY), and the annual figure for FY2025 was $535.9 million, up 127.28%.
  • Free Cash Flow for Q4 2025 was $395.8 million at AdaptHealth, up from $66.8 million in the prior quarter.
  • Over the last five years, Free Cash Flow for AHCO hit a ceiling of $395.8 million in Q4 2025 and a floor of -$149.7 million in Q4 2023.
  • Median Free Cash Flow over the past 5 years was $67.9 million (2021), compared with a mean of $76.3 million.
  • Biggest five-year swings in Free Cash Flow: crashed 1206.71% in 2022 and later surged 5276.62% in 2024.
  • AdaptHealth's Free Cash Flow stood at $99.7 million in 2021, then rose by 23.96% to $123.6 million in 2022, then crashed by 221.17% to -$149.7 million in 2023, then surged by 148.81% to $73.1 million in 2024, then soared by 441.58% to $395.8 million in 2025.
  • The last three reported values for Free Cash Flow were $395.8 million (Q4 2025), $66.8 million (Q3 2025), and $73.3 million (Q2 2025) per Business Quant data.